BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline

Estimated read time 1 min read

BioNTech will invest $200 million and get access to Autolus’ manufacturing sites.

You May Also Like

More From Author

+ There are no comments

Add yours